Literature DB >> 22975362

Risk of second primary malignancies in women with cervical cancer: a population-based study in Taiwan over a 30-year period.

Chao-Yu Chen1, Chyong-Huey Lai, Kuan-Der Lee, Shih-Hao Huang, Yen-Mei Dai, Min-Chi Chen.   

Abstract

OBJECTIVE: Studies conducted in Western countries have reported an increased risk for second primary malignancies after cervical cancer. There is little documentation of ethnic differences in this increased risk, and most of the Asian studies are hospital-based studies with small case numbers.
METHODS: Using population-based data from the Taiwan Cancer Registry for the period 1979-2008, we quantified standardized incidence ratios (SIRs) among 52,972 women with initial diagnoses of cervical cancer.
RESULTS: Among the 52,972 women, 3061 (5.78%) developed second primary cancers during 433,571 person-years of follow-up. Overall, the SIR for developing a subsequent second cancer was significantly greater than that of the general population (1.36 [95% CI, 1.32-1.41]). There was a greater risk for cancers of the esophagus, stomach, small intestine, rectum, lung, bone, non-melanoma skin, uterine corpus, vagina/vulva, bladder, kidney, and leukemia. When further examining age at diagnosis of cervical cancer (<50 and ≥50) for these 12 sites, we found that the risk of second cancers (SIR, <50 and ≥50: 3.08 vs. 1.63) was higher not only in younger patients, except for non-melanoma skin cancer and endometrial cancer, but also within the first 5 years after diagnosis of cervical cancer. The median overall survival for women with cervical cancer was 18.58 years. The second cancers had a negative impact on overall survival after adjusting for age (P<0.001).
CONCLUSIONS: SIR for second cancers was significantly greater than the general population in cervical cancer patients. A young age at the diagnosis of cervical cancer predicted an increased risk. The second cancers worsened overall survival.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22975362     DOI: 10.1016/j.ygyno.2012.09.004

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  10 in total

1.  Survival impact of locoregional metachronous malignancy in survival of lung cancer patients who received curative treatment.

Authors:  Chi-Tsung Wen; Jui-Ying Fu; Ching-Feng Wu; Ming-Ju Hsieh; Yun-Hen Liu; Yi-Cheng Wu; Ying-Huang Tsai; Ching-Yang Wu
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

2.  Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapse.

Authors:  Åsa H Everhov; Sara Ekberg; Angelica Lindén Hirschberg; Karin Bergmark; Angelique Flöter Rådestad; Ingrid Glimelius; Karin E Smedby
Journal:  J Cancer Surviv       Date:  2015-11-12       Impact factor: 4.442

3.  Survival analysis of second primary malignancies after cervical cancer using a competing risk model: implications for prevention and surveillance.

Authors:  Runmei Li; Yue Zhang; Bingqing Ma; Kangming Tan; Henry S Lynn; Zhenyu Wu
Journal:  Ann Transl Med       Date:  2021-02

4.  Second Primary Cancer after Diagnosis and Treatment of Cervical Cancer.

Authors:  Myong Cheol Lim; Young-Joo Won; Jiwon Lim; Yeon-Joo Kim; Sang Soo Seo; Sokbom Kang; Eun Sook Lee; Jae Hwan Oh; Joo-Young Kim; Sang-Yoon Park
Journal:  Cancer Res Treat       Date:  2015-07-17       Impact factor: 4.679

5.  Low Rates of Dual-Site and Concordant Oral-Cervical Human Papillomavirus Infections and Cancers: A Systematic Review.

Authors:  Kelsey H Jordan; Chloe M Beverly Hery; Xiaochen Zhang; Electra D Paskett
Journal:  Front Oncol       Date:  2022-03-29       Impact factor: 6.244

6.  Second Malignancies Following Primary Cervical Cancer Diagnosis: Analysis of the SEER Database.

Authors:  Oluwasegun A Akinyemi; Faith O Abodunrin; Tsion F Andine; Kindha Elleissy Nasef; Bolarinwa Akinwumi; Ayobami Oduwole; Christina Lipscombe; Ademola S Ojo; Mary Fakorede
Journal:  Cureus       Date:  2022-06-21

7.  Secondary Primary Malignancy Risk in Patients With Cervical Cancer in Taiwan: A Nationwide Population-Based Study.

Authors:  Chung-Jen Teng; Leh-Kiong Huon; Yu-Wen Hu; Chiu-Mei Yeh; Yee Chao; Muh-Hwa Yang; Tzeng-Ji Chen; Yi-Ping Hung; Chia-Jen Liu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

8.  Trends in Risks for Second Primary Cancers Associated With Index Human Papillomavirus-Associated Cancers.

Authors:  Ryan Suk; Parag Mahale; Kalyani Sonawane; Andrew G Sikora; Jagpreet Chhatwal; Kathleen M Schmeler; Keith Sigel; Scott B Cantor; Elizabeth Y Chiao; Ashish A Deshmukh
Journal:  JAMA Netw Open       Date:  2018-09-07

9.  Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis.

Authors:  Duncan C Gilbert; Katie Wakeham; Ruth E Langley; Claire L Vale
Journal:  Br J Cancer       Date:  2018-11-28       Impact factor: 7.640

10.  Clinicopathological characteristics and outcomes of metachronous rectal cancer in patients with a history of cervical cancer with and without remote radiotherapy: Reports of 45 cases.

Authors:  Hsinyuan Hung; Jengfu You; Jyming Chiang; Paoshiu Hsieh; Sumfu Chiang; Chengchou Lai; Wensy Tasi; Chienyuh Yeh; Yihjong Chern; Yujen Hsu
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.